Operating Lease, Right-of-Use Asset of Adaptive Biotechnologies Corp from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adaptive Biotechnologies Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Adaptive Biotechnologies Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $41,988,000, a 9.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Adaptive Biotechnologies Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $41,988,000 -$4,542,000 -9.8% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $43,338,000 -$5,183,000 -11% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $44,004,000 -$6,995,000 -14% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $45,767,000 -$6,329,000 -12% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $46,530,000 -$28,733,000 -38% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $48,521,000 -$28,588,000 -37% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $50,999,000 -$27,961,000 -35% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $52,096,000 -$28,667,000 -35% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $75,263,000 -$7,342,000 -8.9% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $77,109,000 -$7,289,000 -8.6% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $78,960,000 -$6,674,000 -7.8% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $80,763,000 -$6,915,000 -7.9% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $82,605,000 -$6,841,000 -7.6% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $84,398,000 -$7,669,000 -8.3% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $85,634,000 -$2,870,000 -3.2% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $87,678,000 -$11,672,000 -12% 31 Dec 2021 10-K 14 Feb 2023 2022 FY
Q3 2021 $89,446,000 +$51,713,000 +137% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $92,067,000 +$54,448,000 +145% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $88,504,000 +$57,446,000 +185% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $99,350,000 31 Dec 2020 10-K 15 Feb 2022 2021 FY
Q3 2020 $37,733,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $37,619,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $31,058,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.